Table 3.
Epidemiological, immunological and clinical profile of COVID-19 infected HCWs
| HCWs characteristics (N = 164) | |
|---|---|
| Exposure to confirmed COVID-19 cases | 33 (20.1%) |
| Number of positive nasopharyngeal swabs | 1.0 (IQR 1.0–1.0), range: 1–4 |
| Sick days | 18.0 (IQR 13.5–25.0) |
| Time length of negativization (days) | 16.0 (IQR 12.0–20.0) |
| Clinical profile (N = 164) | |
| Hospital admission | 9 (5.5%) |
| Presence of symptoms | 148 (90.2%) |
| Fever (ABT > 37.5 °C) | 114 (69.5%) |
| Asthenia | 73 (44.5%) |
| Anosmia | 67 (40.9%) |
| Ageusia | 59 (36.0%) |
| Cough | 59 (36.0%) |
| Neurological symptoms and headache | 42 (25.6%) |
| GI symptoms (nausea and diarrhea) | 35 (21.3%) |
| Dyspnea | 34 (20.7%) |
| Sore throat | 28 (17.1%) |
| Conjunctivitis | 11 (6.7%) |
Notes: COVID-19 = coronavirus-19 disease; HCWs = health care workers; PPE = personal protective equipment; ABT = axillary body temperature; GI = gastrointestinal.
Data are absolute frequency (% in the group) or median value (inter-quartile range, IQR).